Jang Moon, MD

Clinical Focus

• Cirrhosis
• Liver Transplant
• Short Bowel Syndrome

• Cirrhosis
• Liver Transplant
• Short Bowel Syndrome

Locations

RMTI - Liver and Intestinal Transplant Programs

5 East 98th st., 12th Floor, New York, NY, 10029

212-659-9300

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:17

Article:45

Review Article:5

Letter:2

Recent Artifacts

• Postreperfusion syndrome in liver transplantation: Outcomes, predictors, and application for recipient selection
• Evaluation of the fibrosis-4 index for detection of advanced fibrosis among individuals at risk for intestinal failure–associated liver disease
• Tacrolimus time-in-therapeutic range is associated with freedom from acute rejection and graft failure following intestinal transplantation
• The role of endoscopy in the small intestinal transplant recipient: A review
• “Stoma or no stoma”: First report of intestinal transplantation without stoma
• Adult intestinal transplantation in the United States
• Routine surveillance endoscopy and biopsy after isolated intestinal transplantation—Revisiting the gold standard
• Is There a Role for Desensitization in Intestinal Transplantation?
• Prevalence, Evolution, and Risk Factors for Advanced Liver Fibrosis in Adults Undergoing Intestinal Transplantation
• Small-for-size Syndrome Does Not Occur in Intestinal Transplantation Without Liver Containing Grafts

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Moon did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.